View Older Stories

Jul 6, 2026 01:45PM EU approves AbbVie's Tepkinly combo for follicular lymphoma

Jul 6, 2026 06:43AM Abbvie (ABBV) PT Raised to $265 at Cantor Fitzgerald: Broadly Strong Q2 Results Expected

Jul 1, 2026 08:01AM RBC Capital Reiterates Outperform Rating on Abbvie (ABBV)

Jun 30, 2026 06:02AM U.S. House committee opens investigation into Merck, AbbVie China drug trials - Reuters

Jun 29, 2026 04:20PM FDA selects 7 companies for domestic drug manufacturing pilot

Jun 26, 2026 04:52PM FDA approves AbbVie's Skyrizi for children with psoriatic disease

Jun 23, 2026 09:12AM Bernstein SocGen's Thoughts on Abbvie (ABBV) Following APGE Acquisition

Jun 23, 2026 08:00AM Health Canada approves AbbVie's Boey for frown line treatment

Jun 23, 2026 07:24AM Abbvie (ABBV) PT Raised to $273 at Canaccord

Jun 23, 2026 07:22AM Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald after Analyst Call

Jun 23, 2026 05:39AM EU approves AbbVie's Maviret for acute hepatitis C treatment

Jun 23, 2026 04:09AM EU approves AbbVie's Skyrizi for children with plaque psoriasis

Jun 22, 2026 06:23AM AbbVie (ABBV) call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics (APGE), FT reports

Jun 18, 2026 04:07PM AbbVie (ABBV) Declares $1.73 Quarterly Dividend; 3.2% Yield

Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day

Jun 12, 2026 03:03AM AbbVie presents nine-year venetoclax trial results at EHA congress

Jun 8, 2026 08:01AM AbbVie to present blood cancer data at EHA 2026

May 29, 2026 08:00AM AbbVie gets EU approval for expanded VENCLYXTO cancer drug combinations

May 27, 2026 03:38PM FDA approves AbbVie's pivekimab sunirine-PVZY for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare hematologic malignancy

May 22, 2026 05:31AM AbbVie to present oncology pipeline data at 2026 ASCO meeting

May 18, 2026 10:59AM Trump to unveil more discounted prescription drug options - CNBC

May 14, 2026 08:25AM Abbvie (ABBV) PT Raised to $298 at Piper Sandler

May 8, 2026 12:04PM Health officials explore restrictions on certain SSRI antidepressants - Reuters

May 5, 2026 08:05AM AbbVie presents inflammatory bowel disease data at medical conference

Apr 30, 2026 06:59AM Abbvie (ABBV) PT Raised to $265 at Canaccord

Apr 30, 2026 06:11AM BofA Securities Upgrades Abbvie (ABBV) to Buy

Apr 30, 2026 04:25AM Abbvie (ABBV) PT Raised to $244 at Goldman Sachs

Apr 29, 2026 07:48AM AbbVie (ABBV) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance

Apr 29, 2026 12:00AM AbbVie Q1 earnings preview: analysts eye immunology growth trends

Apr 28, 2026 07:01AM EvolveImmune receives $18 million milestone payment from ABBV partnership

Apr 27, 2026 08:05AM AbbVie submits FDA application for SKYRIZI subcutaneous dosing

Apr 23, 2026 04:06PM FDA requests more manufacturing data for AbbVie's botox alternative

Apr 23, 2026 09:20AM Abbvie (ABBV) PT Lowered to $294 at Piper Sandler

Apr 22, 2026 12:28PM AbbVie to build $1.4 billion manufacturing campus in North Carolina

Apr 20, 2026 04:36PM Canaccord Starts Abbvie (ABBV) at Buy, PT set at $262

Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

Apr 10, 2026 08:36AM RBC Capital Reiterates Outperform Rating on Abbvie (ABBV)

Apr 10, 2026 06:57AM Abbvie (ABBV) PT Raised to $249 at Guggenheim

Apr 8, 2026 07:31AM Abbvie (ABBV) PT Lowered to $240 at Cantor Fitzgerald on Bad Sentiment

Mar 30, 2026 08:01AM Allergan Aesthetics presents data on investigational neurotoxin at AAD

Mar 26, 2026 05:45AM Allergan Aesthetics presents 21 research posters at Monaco medical congress

Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'

Mar 12, 2026 06:55AM Guggenheim Reiterates Buy Rating on Abbvie (ABBV)

Mar 9, 2026 11:52AM William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"

Mar 9, 2026 09:35AM BMO Capital Reiterates Outperform Rating on Abbvie (ABBV): today's data "reflective of an opportunity to diversify its business beyond the I&I"

Feb 25, 2026 06:04AM AbbVie (ABBV) 7-Part Filing

Feb 24, 2026 04:07PM RBC Capital Starts Abbvie (ABBV) at Outperform

Feb 23, 2026 11:00AM AbbVie plans $380 million manufacturing expansion in North Chicago

Feb 20, 2026 06:00AM Barclays Starts Abbvie (ABBV) at Overweight

Feb 20, 2026 05:29AM FDA approves AbbVie's VENCLEXTA-acalabrutinib combo for untreated CLL

View Older Stories